Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of FTY720 versus mycophenolate mofetil (MMF,
Roche brand) combined with cyclosporine and corticosteroids in patients receiving a kidney
transplant.